For instance, CCR5 gene-edited primary human CD4+ T cells were found to be resistant to HIV-1 infection in vitro [24,52,53,74], recapitulating results obtained with other gene editing tools, such as TALENs and zinc finger nucleases [75,76]. This evidence concerns the gene CD4 and HIV-1 infection.